Revising Adult RSV Policy: US CDC Moves Toward Risk-Based Vaccine Recommendation

 
• By Bridget Silverman
  
RSV Vaccine
The ACIP work group said to recommend GSK's RSV vaccine for adults age 60-74 at increased risk of severe disease. • Source: Shutterstock
Pink Sheet Podcast

Have you checked out Pink Sheet podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Vaccines

More from Pink Sheet